KING OF PRUSSIA, PA, June 21 /PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has named Howard Moody to the position of Vice-President of Information Technology (IT). In this role, Mr. Moody will be responsible for implementing effective IT applications to improve processes, increase operational efficiencies and fuel business growth in MDS Pharma Services. Mr. Moody will report to MDS Pharma Services President David Spaight and MDS Inc. Chief Information Officer (CIO) Tom Gernon. "As a leading contract research organization, our business relies upon having innovative IT applications to meet our customers' needs on a global scale," said Mr. Spaight. "Mr. Moody's vast experience will enhance our ability to offer our customers innovative IT solutions that support their drug discovery and development initiatives." Mr. Moody's background combines Clinical Laboratory and Contract Research Organization (CRO) experience with more than 30 years of diverse IT positions. Before joining MDS, Mr. Moody was Chief Information Officer at Medifacts International, a CRO in Rockville, Maryland, where he was responsible for global information technology and services. Prior to that role, he worked for Churchill & Harriman, a pharmaceutical company in Princeton, New Jersey, as a Senior Management Consultant. He spent five years at Covance in Princeton, New Jersey, as Chief Information Officer and Senior Vice-President. His experience also includes IT leadership roles at Quest Diagnostics, SmithKline Beecham, and Deluxe Data Systems. A native of New York, Mr. Moody earned a Bachelor of Science degree in Mathematics from the State University of New York and a Master's degree in Computer Science from the University of Wisconsin. About MDS Pharma Services MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at http://www.mdsps.com/. MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly skilled people in 28 countries. Find out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a day. DATASOURCE: MDS Pharma Services CONTACT: For Investors, Sharon Mathers, (416) 675-6777 ext. 34721, ; For Media, Charlene McGrady, (610) 239-7900 ext. 231,

Copyright